Aldesleukin Completed Phase 1 / 2 Trials for Neuroblastomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00006480Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma